St. Petersburg Bekhterev Research Psychoneurological Institute Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2013
NCT02205879
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

St. Petersburg Bekhterev Research Psychoneurological Institute | St.-Petersburg Bekhterev Research Psychoneurological Institute, Russian Federation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 4)

Substance Withdrawal Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6